{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:54:00Z","timestamp":1781859240980,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002964","name":"Cukurova University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002964","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jfo.2026.104914","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:01:37Z","timestamp":1779901297000},"page":"104914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["TNF-\u03b1 blockers and demyelinating lesions in pediatric non-infectious uveitis: Insights from a real world cohort"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5633-9036","authenticated-orcid":false,"given":"P.","family":"Isik Eker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Esen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.G.","family":"Mert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6.","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.K.","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Demircan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2026.104914_bib0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/09273948.2017.1334469","article-title":"Multiple sclerosis-associated uveitis","volume":"25","author":"Cunningham","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2026.104914_bib0195","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ophtha.2017.11.017","article-title":"Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of Care for UveitiS (FOCUS) Initiative","volume":"125","author":"Dick","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2026.104914_bib0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/eye.2011.255","article-title":"Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation","volume":"26","author":"Lee","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.jfo.2026.104914_bib0205","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.survophthal.2015.06.004","article-title":"Anti-tumor necrosis factor-a therapy in uveitis","volume":"60","author":"Cordero-Coma","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2026.104914_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40674-017-0057-z","article-title":"An Update on treatment of pediatric chronic non-infectious uveitis","volume":"3","author":"Sood","year":"2017","journal-title":"Curr Treat Options Rheumatol"},{"key":"10.1016\/j.jfo.2026.104914_bib0215","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/acr.22214","article-title":"Current evidence of anti- tumor necrosis factor a treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs","volume":"66","author":"Simonini","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jfo.2026.104914_bib0220","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/jir.2011.0065","article-title":"Cytokines in autoimmunity: role in induction, regulation, and treatment","volume":"31","author":"Moudgil","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jfo.2026.104914_bib0225","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2026.104914_bib0230","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/09273948.2025.2465776","article-title":"Pediatric uveitis: impact of anti-tumor necrosis factor-alpha on ocular complications","volume":"33","author":"Sharon","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2026.104914_bib0235","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/rheumatology\/kes375","article-title":"Pattern of demyelination occurring during anti-tnf-\u03b1 therapy: a French national survey","volume":"52","author":"Seror","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jfo.2026.104914_bib0240","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamaneurol.2020.1162","article-title":"Association between tumor necrosis factor inhibit\u00f6r exposure and inflammatory central nervous system events","volume":"77","author":"Kunchok","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jfo.2026.104914_bib0245","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1080\/14740338.2017.1372421","article-title":"Autoimmune diseases induced by biological agents: a review of 12,731 cases (BIOGEAS Registry)","volume":"16","author":"P\u00e9rez-De-Lis","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jfo.2026.104914_bib0250","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/09273948.2024.2414917","article-title":"White matter abnormalities in pediatric non-infectious uveitis","volume":"33","author":"Maccora","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2026.104914_bib0255","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00415-008-6020-z","article-title":"Cerebral MRI lesions and anti-tumor necrosis factor-alpha therapy","volume":"255","author":"Winkelmann","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.jfo.2026.104914_bib0260","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.2147\/OPTH.S322445","article-title":"Biological therapy in noninfectious pediatric uveitis: a systematic review","volume":"15","author":"Norcia","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jfo.2026.104914_bib0265","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/annrheumdis-2018-213131","article-title":"Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative","volume":"77","author":"Constantin","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2026.104914_bib0270","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1093\/brain\/awad073","article-title":"The radiologically isolated syndrome: revised diagnostic criteria","volume":"146","author":"Lebrun-Fr\u00e9nay","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.jfo.2026.104914_bib0275","doi-asserted-by":"crossref","first-page":"e992","DOI":"10.1212\/NXI.0000000000000992","volume":"8","author":"Taylor","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jfo.2026.104914_bib0280","first-page":"932","article-title":"Adalimumab in patients with active noninfectious uveitis requiring high-dose corticosteroids: the visual-1 trial","volume":"375","author":"Jaffe","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2026.104914_bib0285","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jfo.2026.104914_bib0290","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ophtha.2017.12.039","article-title":"Safety and efficacy of adalimumab in patients with noninfectious uveitis in an ongoing open-label study: VISUAL III","volume":"125","author":"Suhler","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2026.104914_bib0295","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2174\/1876894601002040160","article-title":"TNF-\u03b1: a paradigm of paradox and complexity in multiple sclerosis and its animal models","volume":"2","author":"Lim","year":"2010","journal-title":"Open Autoimmun J"},{"key":"10.1016\/j.jfo.2026.104914_bib0300","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.autrev.2013.09.002","article-title":"Demyelination and other neurologic adverse events after anti-TNF therapy","volume":"13","author":"Kaltsonoudis","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jfo.2026.104914_bib0305","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/bjophthalmol-2014-305518","article-title":"Characterisation of uveitis in association with multiple sclerosis","volume":"99","author":"Messenger","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2026.104914_bib0310","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6","article-title":"Demyelinating and neurologic events reported in association with tumor necrosis factor \u03b1 antagonism","volume":"44","author":"Robinson","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2026.104914_bib0315","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11910-017-0742-1","article-title":"CNS demyelination with TNF-\u03b1 blockers","volume":"17","author":"Kemanetzoglou","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jfo.2026.104914_bib0320","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0002-9394(02)01702-6","article-title":"Intermediate uveitis in childhood preceding the diagnosis of multiple sclerosis: a 13-year follow-up","volume":"135","author":"Jordan","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2026.104914_bib0325","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/brain\/awt356","article-title":"Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden","volume":"137","author":"Westerlind","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jfo.2026.104914_bib0330","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0161-6420(99)90122-7","article-title":"Pars planitis: clinical features and class II HLA associations","volume":"106","author":"Raja","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2026.104914_bib0335","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12348-024-00403-3","article-title":"Management of uveitis patients on anti-TNF agents who develop demyelinating disease\u00a0\u2013\u00a0a case series","volume":"14","author":"Hamdan","year":"2024","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.jfo.2026.104914_bib0340","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/09273948.2024.2401140","article-title":"Review for disease of the year clinical features and ocular imaging in intermediate uveitis and pars planitis","volume":"33","author":"Ozdal P\u00c7","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2026.104914_bib0345","series-title":"Acute disseminated encephalomyelitis","author":"Anilkumar","year":"2024"},{"key":"10.1016\/j.jfo.2026.104914_bib0350","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00415-015-7694-7","article-title":"Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome","volume":"262","author":"Koelman","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.jfo.2026.104914_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2015.10.002","article-title":"Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis","volume":"289","author":"Horellou","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jfo.2026.104914_bib0360","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.25799","article-title":"Radiologically Isolated syndrome: 10-year risk estimate of a clinical event","volume":"88","author":"Lebrun-Frenay","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jfo.2026.104914_bib0365","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","article-title":"Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders","volume":"121","author":"Levy-Clarke","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2026.104914_bib0370","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1093\/rheumatology\/key208","article-title":"The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis","volume":"58","author":"Holroyd","year":"2019","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551226001403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551226001403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:20:23Z","timestamp":1781857223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551226001403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0181551226001403"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2026.104914","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNF-\u03b1 blockers and demyelinating lesions in pediatric non-infectious uveitis: Insights from a real world cohort","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2026.104914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104914"}}